Literature DB >> 20179497

Preoperative C-reactive protein predicts long-term mortality and hospital length of stay after primary, nonemergent coronary artery bypass grafting.

Tjörvi E Perry1, Jochen D Muehlschlegel, Kuang-Yu Liu, Amanda A Fox, Charles D Collard, Simon C Body, Stanton K Shernan.   

Abstract

BACKGROUND: Preoperative C-reactive protein (CRP) levels more than 10 mg/l have been shown to be associated with increased morbidity and mortality after cardiac surgery. We examine the value of preoperative CRP levels less than 10 mg/l for predicting long-term, all-cause mortality and hospital length of stay in surgical patients undergoing primary, nonemergent coronary artery bypass graft-only surgery.
METHODS: We examined the association between preoperative CRP levels stratified into four categories (< 1, 1-3, 3-10, and > 10 mg/l), and 7-yr all-cause mortality and hospital length of stay in 914 prospectively enrolled primary, nonemergent coronary artery bypass graft-only surgical patients using a proportional hazards regression model.
RESULTS: Eighty-seven patients (9.5%) died during a mean follow-up period of 4.8 +/- 1.5 yr. After proportional hazards adjustment, the 3-10 and > 10 mg/l preoperative CRP groups were associated with long-term, all-cause mortality (hazards ratios [95% CI]: 2.50 [1.22-5.16], P = 0.01 and 2.66 [1.21-5.80], P = 0.02, respectively) and extended hospital length of stay (1.32 [1.07-1.63], P < 0.001 and 1.27 [1.02-1.62], P = 0.001, respectively).
CONCLUSION: We demonstrate that preoperative CRP levels as low as 3 mg/l are associated with increased long-term mortality and extended hospital length of stay in relatively lower-acuity patients undergoing primary, nonemergent coronary artery bypass graft-only surgery. These important findings may allow for more objective risk stratification of patients who present for uncomplicated surgical coronary revascularization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20179497      PMCID: PMC3000538          DOI: 10.1097/ALN.0b013e3181cea3b5

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  27 in total

Review 1.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

Authors:  Paul M Ridker
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.

Authors:  W Koenig; M Sund; M Fröhlich; H G Fischer; H Löwel; A Döring; W L Hutchinson; M B Pepys
Journal:  Circulation       Date:  1999-01-19       Impact factor: 29.690

3.  C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis.

Authors:  T P Zwaka; V Hombach; J Torzewski
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

4.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.

Authors:  P M Ridker; M J Stampfer; N Rifai
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

5.  Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis.

Authors:  Robert Y L Zee; Paul M Ridker
Journal:  Atherosclerosis       Date:  2002-05       Impact factor: 5.162

6.  Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

Authors:  P M Ridker; J E Buring; J Shih; M Matias; C H Hennekens
Journal:  Circulation       Date:  1998-08-25       Impact factor: 29.690

7.  C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.

Authors:  D A Morrow; N Rifai; E M Antman; D L Weiner; C H McCabe; C P Cannon; E Braunwald
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

8.  Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris.

Authors:  H Benamer; P G Steg; J Benessiano; E Vicaut; C J Gaultier; A Boccara; P Aubry; P Nicaise; E Brochet; J M Juliard; D Himbert; P Assayag
Journal:  Am J Cardiol       Date:  1998-10-01       Impact factor: 2.778

9.  Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery.

Authors:  Wei Pan; Tatjana Pintar; James Anton; Vei-Vei Lee; William K Vaughn; Charles D Collard
Journal:  Circulation       Date:  2004-09-14       Impact factor: 29.690

10.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

Authors:  G Liuzzo; L M Biasucci; J R Gallimore; R L Grillo; A G Rebuzzi; M B Pepys; A Maseri
Journal:  N Engl J Med       Date:  1994-08-18       Impact factor: 91.245

View more
  9 in total

1.  GNAS gene variants affect β-blocker-related survival after coronary artery bypass grafting.

Authors:  Ulrich H Frey; Jochen D Muehlschlegel; Jürgen Peters; Simon Body; Christoph Ochterbeck; Amanda A Fox; Stanton K Shernan; Charles D Collard; Peter Lichtner
Journal:  Anesthesiology       Date:  2014-05       Impact factor: 7.892

2.  Increased preoperative C-reactive protein levels are associated with inhospital death after coronary artery bypass surgery.

Authors:  Andrea De Lorenzo; Felipe Pittella; Antonio Rocha
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

3.  Circulating miR-182-5p and miR-5187-5p as biomarkers for the diagnosis of unprotected left main coronary artery disease.

Authors:  Lingping Zhu; Tong Chen; Wenrui Ye; Jun-Yao Wang; Ji-Peng Zhou; Zhen-Yu Li; Chuan-Chang Li
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

4.  Performance of Artificial Intelligence-Based Algorithms to Predict Prolonged Length of Stay after Lumbar Decompression Surgery.

Authors:  Babak Saravi; Alisia Zink; Sara Ülkümen; Sebastien Couillard-Despres; Frank Hassel; Gernot Lang
Journal:  J Clin Med       Date:  2022-07-13       Impact factor: 4.964

5.  Exhaustion, immuno-inflammation, and pathogen burden after cardiac surgery: an exploratory study.

Authors:  Pamela S Miller; Lorraine S Evangelista; Joyce Newman Giger; Otoniel Martinez-Maza; Teresita Corvera-Tindel; Larry Magpantay; Guadalupe Pena; Lynn V Doering
Journal:  Eur J Cardiovasc Nurs       Date:  2013-03-22       Impact factor: 3.908

6.  Depression, C-reactive protein and length of post-operative hospital stay in coronary artery bypass graft surgery patients.

Authors:  Lydia Poole; Tara Kidd; Elizabeth Leigh; Amy Ronaldson; Marjan Jahangiri; Andrew Steptoe
Journal:  Brain Behav Immun       Date:  2013-11-14       Impact factor: 7.217

Review 7.  Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction?

Authors:  Alessandro Parolari; Paolo Poggio; Veronika Myasoedova; Paola Songia; Giorgia Bonalumi; Alberto Pilozzi; Davide Pacini; Francesco Alamanni; Elena Tremoli
Journal:  Front Cardiovasc Med       Date:  2016-01-05

8.  Risk Factors for Duodenal Stump Leakage after Laparoscopic Gastrectomy for Gastric Cancer.

Authors:  Lihu Gu; Kang Zhang; Zefeng Shen; Xianfa Wang; Hepan Zhu; Junhai Pan; Xin Zhong; Parikshit Asutosh Khadaroo; Ping Chen
Journal:  J Gastric Cancer       Date:  2020-02-17       Impact factor: 3.720

9.  Prediction of early C-reactive protein levels after non-cardiac surgery under general anesthesia.

Authors:  Shiroh Nakamoto; Munetaka Hirose
Journal:  PLoS One       Date:  2019-12-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.